A clinical trial on a two-drug therapy for methamphetamine use disorder reduced use of the highly addictive drug for up to 12 weeks after initiation of treatment. Participants in the ADAPT-2 clinical ...
Longtime Microsoft exec and former quantum lead Jeff Henshaw takes a role at IonQ while Heptio co-founder Joe Beda joins ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results